BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9466142)

  • 1. Aiding priority setting in health care: is there a role for the contingent valuation method?
    Olsen JA
    Health Econ; 1997; 6(6):603-12. PubMed ID: 9466142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eliciting several willingness to pay in a single contingent valuation survey: application to health care.
    Luchini S; Protière C; Moatti JP
    Health Econ; 2003 Jan; 12(1):51-64. PubMed ID: 12483760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do ordering effects matter in willingness-to-pay studies of health care?
    Stewart JM; O'Shea E; Donaldson C; Shackley P
    J Health Econ; 2002 Jul; 21(4):585-99. PubMed ID: 12146592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes.
    Donaldson C; Birch S; Gafni A
    Health Econ; 2002 Jan; 11(1):55-70. PubMed ID: 11788982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of the contingent valuation market in health care: a critical assessment.
    Smith RD
    Health Econ; 2003 Aug; 12(8):609-28. PubMed ID: 12898660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The measurement of contingent valuation for health economics.
    Bayoumi AM
    Pharmacoeconomics; 2004; 22(11):691-700. PubMed ID: 15250748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical implications of response acquiescence in discrete-choice contingent valuation.
    Yeung RY; Smith RD; Ho LM; Johnston JM; Leung GM
    Health Econ; 2006 Oct; 15(10):1077-89. PubMed ID: 16518835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness to pay methods in health care: a sceptical view.
    Cookson R
    Health Econ; 2003 Nov; 12(11):891-4. PubMed ID: 14601152
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing community values in health care: is the 'willingness to pay' method feasible?
    Donaldson C; Farrar S; Mapp T; Walker A; Macphee S
    Health Care Anal; 1997 Mar; 5(1):7-29. PubMed ID: 10166053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contingent valuation with an open-ended follow-up question: a test of scope effects.
    Kartman B; Stålhammar NO; Johannesson M
    Health Econ; 1997; 6(6):637-9. PubMed ID: 9466145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the monetary value of health care: lessons from environmental economics.
    Hanley N; Ryan M; Wright R
    Health Econ; 2003 Jan; 12(1):3-16. PubMed ID: 12483757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theory versus practice: a review of 'willingness-to-pay' in health and health care.
    Olsen JA; Smith RD
    Health Econ; 2001 Jan; 10(1):39-52. PubMed ID: 11180568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual responsibility and health-risk behaviour: a contingent valuation study from the ex ante societal perspective.
    van der Star SM; van den Berg B
    Health Policy; 2011 Aug; 101(3):300-11. PubMed ID: 21168930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valuation of health changes with the contingent valuation method: a test of scope and question order effects.
    Kartman B; Stålhammar NO; Johannesson M
    Health Econ; 1996; 5(6):531-41. PubMed ID: 9003940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contingent ranking method--a feasible and valid method when eliciting preferences for health care?
    Slothuus U; Larsen ML; Junker P
    Soc Sci Med; 2002 May; 54(10):1601-9. PubMed ID: 12061490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should we use willingness to pay to elicit community preferences for health care? New evidence from using a 'marginal' approach.
    Shackley P; Donaldson C
    J Health Econ; 2002 Nov; 21(6):971-91. PubMed ID: 12475121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of informal care--a further investigation of the feasibility of contingent valuation in informal caregivers.
    de Meijer C; Brouwer W; Koopmanschap M; van den Berg B; van Exel J
    Health Econ; 2010 Jul; 19(7):755-71. PubMed ID: 19548326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness to pay for a QALY.
    Gyrd-Hansen D
    Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insensitivity to scope in contingent valuation studies: reason for dismissal of valuations?
    Søgaard R; Lindholt J; Gyrd-Hansen D
    Appl Health Econ Health Policy; 2012 Nov; 10(6):397-405. PubMed ID: 22963163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contingent valuation method in health care. An economic evaluation of Alzheimer's disease.
    Nocera S; Telser H; Bonato D
    Dev Health Econ Public Policy; 2003; 8():iii-xi, 1-116. PubMed ID: 15027158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.